CJFClass II
Tetrabromophenolphthalein, Albumin
21 CFR 862.1035 / Clinical Chemistry
CJF is the FDA product code for Tetrabromophenolphthalein, Albumin, a class II device type, regulated under 21 CFR 862.1035. As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- CJF
- Device name
- Tetrabromophenolphthalein, Albumin
- Regulation
- 21 CFR 862.1035
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code CJF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1983 | 1 |
Applicants with the most clearances
Product code CJF| Applicant | Clearances |
|---|---|
| Amresco, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code CJF.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
